Eian Caulder

1.3k total citations
11 papers, 385 citations indexed

About

Eian Caulder is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Eian Caulder has authored 11 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Eian Caulder's work include Cytokine Signaling Pathways and Interactions (5 papers), HER2/EGFR in Cancer Research (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Eian Caulder is often cited by papers focused on Cytokine Signaling Pathways and Interactions (5 papers), HER2/EGFR in Cancer Research (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Eian Caulder collaborates with scholars based in United States and Germany. Eian Caulder's co-authors include Jordan S. Fridman, Robert Newton, Peggy Scherle, Steven Friedman, Kris Vaddi, Allan Lipton, Lois Witters, Wenqing Yao, Xiangdong Liu and Jin‐Cong Zhuo and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Eian Caulder

11 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eian Caulder United States	7	236	192	83	62	58	11	385
Jinli Chang United States	6	156 0.7×	276 1.4×	63 0.8×	41 0.7×	100 1.7×	8	504
Jennifer Volkman United States	5	111 0.5×	239 1.2×	33 0.4×	39 0.6×	57 1.0×	9	365
P A Algate United States	7	162 0.7×	438 2.3×	86 1.0×	58 0.9×	46 0.8×	9	617
Sinto Sebastian United States	8	188 0.8×	265 1.4×	76 0.9×	51 0.8×	67 1.2×	11	412
Juanita Wizniak Canada	7	70 0.3×	172 0.9×	152 1.8×	117 1.9×	31 0.5×	9	360
C. Bouchet France	9	202 0.9×	127 0.7×	87 1.0×	25 0.4×	309 5.3×	16	403
Oisun Jung United States	12	113 0.5×	250 1.3×	59 0.7×	26 0.4×	57 1.0×	15	410
Jessie-F. Fecteau United States	5	137 0.6×	222 1.2×	41 0.5×	20 0.3×	38 0.7×	5	341
Lucia Nobili Italy	15	120 0.5×	385 2.0×	219 2.6×	54 0.9×	136 2.3×	24	597
Roza Zandi Denmark	7	264 1.1×	324 1.7×	19 0.2×	62 1.0×	103 1.8×	9	540

Countries citing papers authored by Eian Caulder

Since Specialization

Citations

This map shows the geographic impact of Eian Caulder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eian Caulder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eian Caulder more than expected).

Fields of papers citing papers by Eian Caulder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eian Caulder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eian Caulder. The network helps show where Eian Caulder may publish in the future.

Co-authorship network of co-authors of Eian Caulder

This figure shows the co-authorship network connecting the top 25 collaborators of Eian Caulder. A scholar is included among the top collaborators of Eian Caulder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eian Caulder. Eian Caulder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Li, Jun, Eian Caulder, Margaret Favata, et al.. (2015). Abstract 779: Blockade of the IL-6/JAK/STAT3 signaling pathway inhibits pancreatic tumor cell growth in 3D spheroid cultures and in xenograft models. Cancer Research. 75(15_Supplement). 779–779. 1 indexed citations

Stubbs, Matthew C., Xiaoming Wen, Eian Caulder, et al.. (2015). Abstract 691: Activity of the BET inhibitor INCB054329 in models of multiple myeloma. Cancer Research. 75(15_Supplement). 691–691. 1 indexed citations

Li, Jun, Margaret Favata, Eian Caulder, et al.. (2010). INCB16562, a JAK1/2 Selective Inhibitor, Is Efficacious against Multiple Myeloma Cells and Reverses the Protective Effects of Cytokine and Stromal Cell Support. Neoplasia. 12(1). 28–38. 62 indexed citations

Liu, Phillip C.C., Eian Caulder, Jun Li, et al.. (2009). Combined Inhibition of Janus Kinase 1/2 for the Treatment of JAK2V617F-Driven Neoplasms: Selective Effects on Mutant Cells and Improvements in Measures of Disease Severity. Clinical Cancer Research. 15(22). 6891–6900. 15 indexed citations

Fridman, Jordan S., Eian Caulder, Xiaoming Wen, et al.. (2009). Abstract #2848: Small molecule inhibitors of JAK1/2 improve physiological and functional measures of cancer-associated cachexia. Cancer Research. 69. 2848–2848. 1 indexed citations

Burger, Renate, Steven Le Gouill, Yu-Tzu Tai, et al.. (2009). Janus kinase inhibitor INCB20 has antiproliferative and apoptotic effects on human myeloma cellsin vitroandin vivo. Molecular Cancer Therapeutics. 8(1). 26–35. 47 indexed citations

Vaddi, Krishna, et al.. (2008). Selective JAK inhibition proves efficacious in epithelial cancer models. Journal of Clinical Oncology. 26(15_suppl). 14592–14592. 1 indexed citations

Witters, Lois, Peggy Scherle, Steven Friedman, et al.. (2008). Synergistic Inhibition with a Dual Epidermal Growth Factor Receptor/HER-2/neu Tyrosine Kinase Inhibitor and a Disintegrin and Metalloprotease Inhibitor. Cancer Research. 68(17). 7083–7089. 87 indexed citations

Fridman, Jordan S., Eian Caulder, Michael Hansbury, et al.. (2007). Selective Inhibition of ADAM Metalloproteases as a Novel Approach for Modulating ErbB Pathways in Cancer. Clinical Cancer Research. 13(6). 1892–1902. 114 indexed citations

10.

Liu, Xiangdong, Jordan S. Fridman, Qian Wang, et al.. (2006). Selective inhibition of ADAM metalloproteases blocks HER-2 extracellular domain (ECD) cleavage and potentiates the anti-tumor effects of trastuzumab. Cancer Biology & Therapy. 5(6). 648–656. 45 indexed citations

11.

Jackson, Jeffrey R., Aidan G. Gilmartin, Steven D. Knight, et al.. (2006). A second generation KSP inhibitor, SB-743921, is a highly potent and active therapeutic in preclinical models of cancer. 12. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact